The non-structural protein NS3 of hepatitis C virus has been expressed in bacteria as a polyhistidine fusion protein which can be produced in a soluble form and easily purified by affinity chromatography. Using an in vitro transcription and translation system we have been able to demonstrate that this protein can proteolytically process substrate molecules derived from the nonstructural region of the polyprotein. Using this assay system we have been able to optimize basic biochemical characteristics of the purified enzyme. Parallel experiments show that the full-length NS3 protein also possesses ATPase activity, indicating the bifunctional nature of the protein. In contrast, purified NS3 in which the predicted catalytic serine has been mutated loses protease but retains ATPase activity.
Introduction
Hepatitis C virus (HCV) is the major aetiological agent of post-transfusion non-A non-B hepatitis (Choo et al., 1989) . Cloning and sequence analysis has shown that the genome is approximately 9400 nucleotides in length with a single large open reading frame (ORF) encoding a polyprotein of between 3010 and 3033 amino acids (Kato et al., 1990; Choo et al., 1991 ; Takamizawa et al., 1991) . Genetic organization of the HCV genome is similar to the flavivirus and pestivirus genera, with the structural proteins (core, E1 and NS1/E2) located in the amino-terminal region and the non-structural proteins in the carboxy-terminal region of the polyprotein (Hijikata et al., 1991; Grakoui et al., 1993a; Tomei et al., 1993) . There is good evidence that non-structural protein NS3, with a molecular mass of 70 kDa, possesses both protease and ATPase functions located in its amino-and carboxyterminal regions, respectively. Indeed a carboxy-terminal fragment of NS3 has been expressed and purified from bacteria and shown to possess NTPase activity characteristic of a viral helicase (Suzich et al., 1993) .
Several groups have now shown that the NS3 protein also possesses protease activity. Sequence analysis of the NS3 region from a number of different isolates of HCV indicates that it possesses a totally conserved catalytic triad of His-1083 , Ser-1165 and Asp-1107 * Author for correspondence. Fax +44 181 633 3532. of serine proteases. Recombinant DNA clones coding for the non-structural proteins have been constructed and when translated the precursor protein is rapidly and efficiently cleaved into mature viral proteins both in vitro (Bartenschlager et al., 1993; Hijikata et al., 1993; D'Souza et aL, 1994) and in cellular systems (Eckart et al., 1993; Grakoui et al., 1993b) . This processing was abolished by specific mutation of Ser-1165 in NS3, which supports a serine protease catalytic mechanism. These studies also showed that the cleavage between NS3 and NS4A occurred extremely rapidly and could only be mediated in cis. In contrast, when mutant substrates were synthesized in mammalian cells and processed by cotransfected NS3-expressing clones, the downstream cleavage sites NS4A-NS4B, NS4B-NS5A and NS5A-NS5B could all be proteolytically cleaved in trans.
In order to carry out detailed characterization of this enzyme in terms of its substrate specificity, kinetics and sensitivity to inhibitors, a reproducible in vitro enzyme assay is essential. This paper is the first to report an in vitro, trans processing assay for HCV NS3 protease. We show the expression and purification of full-length NS3 from bacteria which is proteolytically active on a specific polyprotein substrate in trans. We also show that the same recombinant protein which possesses protease function has NTPase activity, indicating the bifunctional nature of the HCV NS3 protein. Furthermore, recombinant enzyme which has been mutated to abolish its protease activity still retains its ATPase property.
Methods
Plasmid constructs. Plasmid A1027 (D'Souza et al., 1994) contains continuous HCV sequence from the beginning of NS3 at amino acid 1027 to the 3' untranslated region of the genome. Plasmid A5A/5B was constructed by deletion of an internal NheI fragment from A1027 resulting in a plasmid expressing amino acids 2203 (in NS5A~3010. This plasmid was converted to A5A/A5B by deletion from an internal HindIII site to a HindIII site in the polylinker leaving a plasmid expressing amino acids 2203-2506. Mutation of the NS3 protease active site Set-1165 to alanine (S-A) was performed by a standard PCR mutagenesis procedure.
Plasmids pRSET-NS3 and pRSET-NS3(S-A), expressing wild-type NS3 or S-A mutant NS3 were constructed by truncation of A1027 or A1027(S-A) at the 3' end such that it expressed NS3 alone. This was achieved by replacing a 300 bp SacI-HindIII fragment with one incorporating an artificial translation termination codon into each plasmid. This fragment was generated by PCR on the parent vector A1027 using primers 5' GTGTGAGTGTTATGACGCGGG 3' and 5' TCAAGCTTACGTGACGACCTCCAGGTCGGC 3'. The resultant PCR fragment was cloned as a SacI-HindIII fragment into A1027 or A1027(S-A) to generate pGEM-NS3 and pGEM-NS3(S-A), respectively. In each case the NS3 gene was then removed on an NheI-HindIII fragment and cloned into the pRSET vector (Invitrogen).
Purification of recombinant NS3 and NS3(S-A)
. Escherichia coli strain JM109(DE3) containing the plasmid pRSET-NS3 or pRSET-NS3(S-A) was propagated on minimum ampicillin plates at 30 °C and inoculated into 500 ml LB broth cultures containing ampicillin. Cultures were grown to the logarithmic growth phase prior to induction with IPTG for a further 2 h at 30 °C. Following induction, bacteria were harvested by centrifugation and resuspended in 40 mM-phosphate buffer pH 8.0 and 0"5 M-NaC1.
Pellets from five 500 ml cultures were lysed by three passages through a French press at 4 °C. Insoluble material was removed by centrifugation at 25000g for 1 h at 4 °C and the clarified supernatant was loaded onto a 50 ml metal chelate chromatography column previously equilibrated in 40 mM-Na2HPO 4 pH 8.0 and 0-5 M-NaCI. The column was washed with 10 volumes of 40 mM-Na~HPO 4 pH 6-0 and 0.5 MNaC1 and the protein eluted at 4 °C using a 50 ml pH gradient from pH 6.0 to pH 4.0. Fractions (5 ml) were collected and 50 gl aliquots from each fraction were analysed by PAGE and proteins visualized by Coomassie blue staining.
Fractions containing the 70 kDa protein expected from fulMength NS3 were pooled, the pH adjusted to pH 8.0 with 0.1 M-NaOH and recycled through the affinity column. Approximately 0.5 mg of purified protein was produced from 1 1 of bacterial culture. The purity of the final product was approximately 90 %.
In vitro NS3 protease assay. In all experiments recombinant DNA clones were analysed using a coupled transcription translation system (TNT; Promega). Typically, DNA was purified using Wizard minipreps (Promega) and approximately 1 gg was added directly to a 25 ~tl TNT reaction in the presence of [3~S]methionine and incubated for 1.5 h at 30 °C. For experiments to assess proteolytic cleavage of pre-formed substrate, purified protease (approximately 0.05 gg) was either added directly to the TNT reaction mix and incubated for a further 3 h or alternatively 2 lal of the TNT reaction mixture was diluted 10-fold in HEPES buffer (0.05 M-HEPES pH 7'6, 1 mM-DTT, 3 mM-MgC12, 8 mM-CHAPS) containing approximately 0.05 gg of purified NS3 and incubated for a further 3 h at 30 °C. Aliquots were removed and analysed by SDS-PAGE (Laemmli, 1970) and fluorography after soaking in Amplify (Amersham).
Detection of NTPase activity. NTPase activity was assessed as described by Suzich et al. (1993) with purified recombinant NS3. Hydrolysis of [~-3~P]ATP was analysed by TLC on polyethylenimine cellulose sheets which were then exposed to X-ray film (Suzich et al., 1993) .
Results

Expression and purification of recombinant NS3 in bacteria
Several laboratories have shown that expression of the non-structural coding region from NS3 through to the end of the HCV genome results in spontaneous processing of the polyprotein into discrete viral products. This processing is mediated by the serine protease activity located in the viral NS3 protein. In order to produce sufficient quantities of protein for detailed biochemical and structural studies we attempted to express the protein to high levels in E. coli. Initially the region corresponding to the complete coding sequence for NS3 (Grakoui et al., 1993b) was modified by PCR and cloned into a pRSET expression vector in such a way that the NS3 sequence was fused downstream of a polyhistidine tract gene with an in-frame translational termination codon at the 3' end ( Fig. 1 ). This strategy also results in the presence of 14 additional non-virus encoded amino acids at the amino terminus of NS3. Following induction the resultant clones were analysed for expression of NS3 by Western blotting with an NS3-specific antiserum (data not shown). Those clones giving positive signals were then used for larger scale experiments and polyhistidine fusion proteins were analysed by metal chelate chromatography. Proteins binding to the column were eluted using a pH gradient and the bound proteins were analysed by PAGE. Fig. 2 shows a typical column profile of expressed proteins from pRSET-NS3. Fractions 15-17 clearly show the elution of a protein of approximately 70 kDa, the expected size of the NS3 fusion protein. The identity of this protein was confirmed by Western blotting. In order to ensure that any subsequent enzymatic activity which we could detect was due to NS3 and not to contaminating bacterial protein,
Terminal amino acid sequences of pRSET-NS3. The NS3 gene was cloned into a bacterial expression vector (pRSET) such that it was fused in-frame with an amino-terminal extension comprising a polyhistidine tract and linker sequences. The first amino acid of authentic HCV NS3 (Ala-1027) is indicated. At the 3' end of the gene the sequence was modified so that the natural terminal amino acid of NS3 was followed by a synthetic translational termination codon. Lysates from induced cultures were analysed by metal chelate chromatography and bound proteins were eluted using a pH 6-0 to pH 4-0 gradient. Aliquots from each fraction were analysed by SDS-PAGE followed by staining with Coomassie Blue. The portion of the gel corresponding to fractions 10 to 20 is shown along with molecular mass markers (lane M). similar experiments were carried out expressing an NS3-polyhistidine fusion protein in which the active site Ser-l165 had been mutated to an alanine [NS3(S-A)]. Identical elution profiles were observed from metal chelate chromatography of these clones.
In vitro trans cleavage of NS3-5(S-A) substrate by NS3
The presence of protease activity in the elution peaks from either wild-type or S-A mutant NS3 was assessed using an in vitro transcription-translation (TNT) system (Fig. 3) . When the wild-type substrate from the beginning of NS3 through to the end of NS5 was used in a TNT system, clear auto-processing activity was observed with the appearance of discrete mature virus products as well as specific processing intermediates ( Fig. 3; lane 1) . In contrast, TNT analysis of NS3-5(S-A) in which the serine residue at amino acid 1165 had been mutated to alanine resulted in the synthesis of the uncleaved NS3-NS5 polyprotein with no evidence of post-translational processing (lane 2), thus confirming that mutation of this putative active serine site in NS3 abolishes the proteolytic activity of the protein. However, when a plasmid expressing wild-type NS3 alone (pGEM-NS3) was coexpressed with the mutant NS3-5(S-A) substrate the pattern of proteins produced was different (lane 3). Apart from the intense band at 70 kDa, which was the NS3 protein produced from pGEM-NS3, the major difference observed was a band at 65 kDa. Since this protein was not present in translations from pGEM-NS3 alone (data not shown) it must have been produced by trans proteolytic processing of the mutant substrate. In confirmation of this, a specific radioimmunoprecipitation assay (RIPA) indicated that the 65 kDa protein was NS5B. Shorter exposure of the gel shown in Fig. 3 revealed the presence of a second protein product of 150 kDa corresponding in size to NS3-NS4A-NS4B-NS5A. Further RIPA analysis showed that it was also possible to detect a protein of approximately 34 kDa using an NS4-specific antiserum. However, this product was only seen in samples in which wild-type NS3-5 was expressed (e.g. lane 1) and was never observed in any of the trans cleavage reactions using the mutant substrate.
Since the size of this protein corresponds to NS4A-NS4B, its absence suggests that in the trans cleavage experiments processing at the NS4A-NS4B and NS4B-NS5A junctions does not occur efficiently. Furthermore, the release of NS5B was the only reproducible event we could observe in the trans cleavage reactions and this suggests that the NS5A-NS5B site is the most susceptible to proteolytic cleavage in trans.
Having shown the ability of co-expressed NS3 to process the mutant substrate we next examined the ability of the purified recombinant enzymes to show the same activity. Addition of the partially purified NS3 fusion protein to TNT lysates containing the NS3-5(S-A) substrate again resulted in the appearance of small amounts of NS5B, indicating proteolytic cleavage at the NS5A-NS5B junction. This activity was evident whether the recombinant NS3 was added post-translationally ( Fig. 3; lane 4) or if the enzyme was present when the nascent substrate was being produced (lane 5). Production of NS5B did not occur when purified NS3(S-A) was added to the system (lane 6) confirming that the observed proteolytic processing was mediated by the recombinant wild-type NS3.
NS3-mediated trans processing of truncated substrates containing the NS5A-NS5B cleavage site
Although there was evidence of processing using this system it was clear that the efficiency of processing was poor. In particular, cleavage at the NS5A-NS5B junction was considerably more evident than at the other sites but still occurred at rather low levels
In an attempt to try to improve the efficiency of this cleavage, truncated substrates were produced in which only the NS5A-NS5B site and its flanking sequences were present. Two truncated substrates were produced: A5A/5B, extending from amino acid 2203 in NS5A to the end of NS5B and A5A/A5B, spanning the region from amino acid 2203 in NS5A through to amino acid 2506 in NS5B. The predicted sizes of the uncleaved products of these constructs are 90 kDa and 33 kDa, respectively, but the observed precursors in TNT analysis were 90 kDa and 45 kDa ( Fig. 4; lanes 1 and 6) . The anomalous migration of the smaller precursor was a consistent observation and can possibly be ascribed to the very high proportion of acidic amino acids in this portion of NS5A. Both constructs produced precursors which were cleaved into smaller molecules by addition of purified recombinant NS3 either post-translationally ( Fig. 4; lanes 2 and 7) or during substrate synthesis (lanes 4 and 9). In contrast no cleavage occurred when NS3(S-A) recombinant enzyme was added (lanes 3, 5, 8 and 10), again confirming the processing to be mediated by the serine protease activity in the recombinant NS3. Both substrates produced a processed moiety corresponding to the A5A fragment (lanes 2, 4, 7 and 9) and a second fragment of either NS5B (65 kDa) or ANS5B (9 kDa). The identities of these processed products were confirmed by RIPA using specific antisera (data not shown) and the precise location of their cleavage was determined by radiochemical sequencing. This showed that the processing mediated by the recombinant NS3 enzyme at the NS5A-NS5B junction was occurring at the cysteine/ serine site at amino acid 2421; this site has previously been shown by others to be the natural cleavage site at the NS5A-NS5B junction (Grakoui et al., 1993a, b) . Further work showed that the NS3-induced cleavage of pre-formed A5A/A5B was reproducible and that both substrate and enzyme could be stored without loss of activity. This enabled us to undertake further characterization of the protease activity.
Optimization of NS3 protease activity
Although cleavage at the NS5A-NS5B site was readily observed when recombinant enzyme was added to the TNT reaction mixture, we reasoned that more efficient cleavage would occur if the reaction conditions were Following incubation, protein products were visualized by SDS-PAGE and autoradiography and the ratios of uncleared precursor to product were quantified by densitometry. Cleavage reactions were subsequently set up using the same substrate under these optimized conditions (d) in the presence of no enzyme (lane 1), purified NS3(S-A) (lane 2) or purified wild-type NS3 (lane3) and again assessed by SDS-PAGE and autoradiography.
optimized. We therefore examined the effect ofpH, Mg 2+ ions and detergents such as CHAPS upon the cleavage reaction. Fig. 5 shows that there is a pH optimum of approximately pH 7.6, that Mg ~+ ions are critical for efficient cleavage and that the addition of CHAPS considerably improves the cleavage efficiency. Using these conditions we were able to improve considerably the ratio of product to precursor (Fig. 5; lane 3) but, as expected, the addition of NS3(S-A) showed no proteolytic activity (lane 2).
Effects of classical protease inhibitors on proteolytic activity of NS3
The effect of known serine protease inhibitors on the activity of the HCV protease was studied. Purified NS3 was added to the A5A/A5B substrate in the presence of a series of classical serine protease inhibitors and the effect visualized by PAGE. Three well-characterized inhibitors [diisopropyl fluorophosphate (DIP; Fig. 6 , lane 1), 3,4-dichloroisocoumarin (lane 4) and aprotinin (lane 5)] had no observable effect on the protease activity even at very high concentrations (Fig. 6) . However, both N-tosyl-L-phenylalanine chloromethyl ketone (TPCK) and N0~-p-tosyl-L-lysine chloromethyl ketone (TLCK) showed appreciable inhibitory activity but, again, only at high concentrations (lanes 2 and 3, respectively).
A TPase activity of purified NS3
In addition to the serine protease motif situated in NS3 there are also motifs characteristic of NTP-binding and helicase activities towards the carboxy terminus of the protein. Furthermore, a truncated protein extending from amino acids 1193 to 1657 of NS3 has been purified after expression in E. coli and shown to possess poly(U)-stimulated NTPase activity. We therefore examined our proteolytically active full-length NS3 protein for similar activity. Fig. 7 shows that ATPase activity was only observed in those fractions of an affinity column which contained the proteolytically active NS3. Similar experiments indicated that the purified NS3(S-A) protein also possessed this activity despite the loss of its proteolytic ability (data not shown). Experiments using column eluates from control bacteria showed no activity. These results clearly demonstrate that the purified recombinant protein retains both of the biochemical functions associated with NS3.
D i s c u s s i o n
Cloning and sequencing of the NS3 region of HCV had predicted that the protein should possess both serine protease and N T P a s e / R N A helicase activity (Miller & Purcell, 1990 ) and these predictions have been confirmed by experimental data (Eckert et al., 1993; Grakoui et al., 1993a, b; Tomei et al., 1993; Bartenschlager et aL, 1993; Suzich et al, 1993) . Both in vitro translation and transient expression in mammalian cells have shown that NS3 is a serine protease and is responsible for the proteolytic processing of the non-structural region of the HCV polyprotein. Furthermore, a carboxy-terminal fragment from NS3 has been expressed and purified from bacteria and shown to be able to hydrotyse nucleoside triphosphates in vitro (Suzich et al., 1993) . Until now there have been no similar reports on the purification of fulllength recombinant NS3 protein showing both serine protease and NTPase functions or of an amino-terminal fragment of NS3 displaying protease activity. Although the two activities seem to lie on the same protein molecule it appears that they are functionally independent, since mutation of the active site of the protease has no effect on the NTPase activity and the active NTPase domain can be produced in the absence of the amino terminus of the molecule (Suzich et al., 1993) .
There have been no reports of natural processing of the molecule into the two functional domains. Although the NS3-mediated cleavage sites show some degree of sequence similarity the rate of cleavage at particular sites varies significantly. Several groups have shown that the NS3-NS4A cleavage occurs extremely rapidly and that this cleavage only occurs in cis, whereas cleavage at all the other sites can be mediated in trans. Significantly the amino acids flanking the cleavage site at NS3-NS4A are different from those flanking the down- stream trans-processed sites. However, we and others have also shown that the trans cleavage sites differ greatly in their rates of cleavage and there is evidence that the NS4A protein is required as a co-factor for the efficient NS3-mediated cleavage of at least some of the downstream sites (Bartenschlager et al., 1994; Failla et al., 1994) . Using an in vitro system it is clear that the most efficiently processed trans site is NS5A-NS5B since mature NS5B and a NS4A-NS4B-NS5A precursor can easily be seen (D'Souza et al., 1994) and cleavage at this site is the least affected by the NS4A co-factor (Failla et al., 1994) . The data produced in this paper show that this site is also the most susceptible to cleavage by exogenously added recombinant enzyme. The substrate initially used in these studies was an NS3-NS4-NS5 molecule in which the NS3 protease moiety had been inactivated by mutagenesis and the only site at which cleavage could be easily detected was the NS5A-NS5B junction. This was the case when purified NS3 protein was added to the TNT lysate either during or after the transcription-translation reaction. This contrasts with the cleavage pattern produced when wild-type NS3-5 is transcribed and translated alone, when efficient cleavage at all sites is observed. There are several potential explanations for the restricted processing observed when exogenous NS3 is used to cleave the mutant NS3-5(S-A) polyprotein in trans. Firstly, the polyprotein may fold inappropriately if NS3 is not released by the cis cleavage, so that only the NS5A-NS5B site is accessible. Secondly, the lack of free NS4A, as a result of the lack of processing at the NS3-NS4A junction, may restrict its ability to improve the efficiency of cleavage at the other sites; this is unlikely since Failla et al. (1994) have shown that NS4A can function as part of a larger precursor. Thirdly, although most of the sites are amenable to cleavage in trans, this does not preclude that they may also be naturally cleaved in cis and this element would be absent from these experiments. At present we cannot distinguish between these possibilities. The lack of significant amino acid similarities around each cleavage site in different isolates of the virus (Grakoui et al., 1993b) tends to support the hypothesis that structural recognition of the substrate may be more important than specific amino acid sequences around the cleavage site. This could explain the superior cleavage of the truncated substrates A5A/5B and A5A/A5B compared to NS3-5(S-A). This suggests that truncation of the substrate allows it to fold into a more appropriate conformation suitable for NS3 recognition.
The synthesis and purification of an active bifunctional protein and particularly the ability to cleave a preformed substrate significantly improves our ability to characterize the enzymatic properties such as the mechanism of action, kinetics and substrate specificity. Optimization of the incubation conditions for the processing of preformed substrate by purified NS3 with respect to pH, Mg 2÷ and CHAPS led to a marked improvement in the extent of cleavage. The reproducibility of the reaction under these optimized conditions makes it suitable for the examination of potentially inhibitory compounds. Most importantly it opens the way to physicochemical characterization of the protein and to the development of specific inhibitory molecules which may have therapeutic potential in HCV-induced disease. When conventional inhibitors of serine proteases were investigated in this system it was interesting to note that only a limited number of them had any effect and then only at extremely high concentrations. This suggests that the HCV NS3 serine protease has properties distinct from cellular serine proteases and should therefore allow the development of specific non-toxic inhibitors as antiviral agents.
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